The Discounted Cash Flow (DCF) valuation of Corcept Therapeutics Inc (CORT) is 55.51 USD. With the latest stock price at 69.53 USD, the upside of Corcept Therapeutics Inc based on DCF is -20.2%.
Based on the latest price of 69.53 USD and our DCF valuation, Corcept Therapeutics Inc (CORT) is a sell. selling CORT stocks now will result in a potential gain of 20.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.3% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 35.65 - 141.25 | 55.51 |
| Upside | -48.7% - 103.2% | -20.2% |